Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma

NCT00654732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Classic Hodgkin Lymphoma
Lugano Classification Stage III Hodgkin Lymphoma AJCC v8
Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8

Interventions

DRUG: Bleomycin
DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Rituximab
DRUG: Vinblastine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]